Neurocrine Biosciences Inc. logo

Neurocrine Biosciences Inc.

NBIX | NASDAQ
Chart Builder DCF Calculator
$146.74
+$0.64 (+0.44%)
Nov 2, 2026, 3:45 PM ET · Market open
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Cash & Equivalents
332.4M 266.5M 713M 340.2M 264M 194.1M 233M 349.1M 139.7M 396.3M 251.1M 293.7M 160.2M 103.8M 262.9M 212.2M 163.3M 270.2M 340.8M 311.1M 368M 352.6M
Short-Term Investments
57.4M 1.05B 767.4M 774.6M 711.6M 749.4M 843.1M 878.9M 899.2M 814.3M 780.5M 801.4M 816.5M 790.8M 726.4M 587.2M 485M 394.7M 370.5M 454.8M 516.9M 521.1M
Long-Term Investments
239.2M 1.48B 1.18B 1.12B 961.3M 909.5M 864.3M 770.6M 781.4M 863.9M 849.4M 587.5M 515.6M 380.3M 401.5M 457.5M 489M 632.3M 624.4M 549M 376.7M 288.5M
Other Long-Term Assets
208.4M 73.6M 59.5M 20.3M 21.6M 15.3M 15.5M 61.6M 57.8M 50.9M 49.6M 43.1M 35.9M 24.9M 25M 10.5M 10M 10.1M 4.4M 3.2M 3.2M 4.6M
Receivables
887M 768.1M 686.8M 728M 595.7M 516M 479.1M 481.1M 468.2M 450.7M 439.3M 417.8M 387.6M 391.6M 350M 301.2M 279M 263.5M 185.5M 163.8M 158.5M 147.8M
Inventory
104.2M 64.5M 69M 69.3M 56.9M 59.1M 57.4M 45.8M 42.5M 37.2M 38.3M 28.8M 31.7M 33.4M 35.1M 37M 29.3M 29M 30.5M 25.5M 28.3M 30.1M
Other Current Assets
39.4M 62.5M 115.8M 68.2M 120.7M 119.3M 63.6M 121.7M 120.2M 100.5M 97.8M 108.2M 100.6M 113.2M 79.1M 67.9M 62.7M 60.8M 45.5M 50.5M 38.4M 33.8M
Total Current Assets
1.64B 2.44B 2.52B 2.16B 1.75B 1.64B 1.72B 1.88B 1.67B 1.8B 1.61B 1.65B 1.5B 1.43B 1.45B 1.21B 1.02B 1.02B 972.8M 1.01B 1.11B 1.09B
Property-Plant & Equipment
538.5M 538M 545.2M 566.2M 584M 589.2M 592M 337.3M 343M 346.1M 347.3M 149.6M 149.1M 147.2M 145.6M 150.5M 159M 158.6M 155.8M 149M 150.3M 142.3M
Goodwill & Intangibles
2.73B n/a n/a 35.7M 37.2M 36.4M 36.5M 34.5M 33.5M 34.3M 35.5M 34.9M 36.9M 37.2M 37.2M n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
3.72B 2.47B 2.11B 2.11B 2.14B 2.05B 1.99B 1.66B 1.64B 1.67B 1.64B 1.2B 1.12B 927M 915.2M 937.9M 986.4M 1.13B 1.1B 1.01B 846.3M 761M
Total Assets
5.36B 4.91B 4.63B 4.27B 3.89B 3.69B 3.72B 3.54B 3.31B 3.47B 3.25B 2.85B 2.61B 2.36B 2.37B 2.14B 2.01B 2.14B 2.07B 2.02B 1.96B 1.85B
Account Payables
142M 120M 104.9M 119.9M 104.6M 110M 99.9M 95.7M 107.2M 87.3M 133.3M 93.8M 391.6M 355.7M 67.3M 297.8M 265.7M 235.9M 51.5M 205.9M 190.9M 171.9M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a 259M 170.1M 169.9M 187.4M n/a 169.4M 186.5M 17.1M 16.9M n/a 15.5M 15M 12.2M
Other Current Liabilities
481.5M 371.7M 423.9M 396.7M 317M 259.8M 297.8M 253M 221.3M 265.2M 261.4M 253.4M 3.5M 800K 225.4M 800K 2.9M 700K 133.3M 4.5M 7M 5.9M
Total Current Liabilities
874.5M 831.7M 743.4M 638M 546.3M 522.9M 507.7M 429.7M 398.5M 712.9M 654.8M 691.6M 582.5M 374.1M 537.7M 485.1M 285.7M 253.5M 245.8M 225.9M 212.9M 190M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 169.5M n/a n/a 169M 377.7M 335.1M 330.7M 326.3M 322M
Other Long-Term Liabilities
297.7M 260.9M 219.7M 195.7M 210.1M 181.6M 166.2M 135M 141.1M 120.5M 106.3M 68.6M 88.5M 41.3M 29.7M 17.1M 28M 19.7M 12.3M 8.3M 29M 21.3M
Total Long-Term Liabilities
791M 667.1M 635M 624.1M 649.2M 629.1M 621.3M 386.4M 397.3M 373.4M 364.6M 154.5M 177.6M 301.2M 123.2M 113.7M 296.6M 499.9M 452.7M 445.4M 464.3M 450.8M
Total Liabilities
1.67B 1.5B 1.38B 1.26B 1.2B 1.15B 1.13B 816.1M 795.8M 1.09B 1.02B 846.1M 760.1M 675.3M 660.9M 598.8M 582.3M 753.4M 698.5M 671.3M 677.2M 640.8M
Total Debt
401.8M 406.2M 415.3M 428.4M 439.1M 447.5M 455.1M 251.4M 256.2M 511.9M 428.4M 273.6M 276.5M 277.5M 262.9M 283.1M 285.7M 497.1M 440.4M 452.6M 450.3M 441.7M
Book Value
3.69B 3.41B 3.25B 3B 2.69B 2.54B 2.59B 2.72B 2.51B 2.39B 2.23B 2B 1.85B 1.68B 1.71B 1.54B 1.42B 1.39B 1.37B 1.35B 1.28B 1.21B
Book Value Per Share
35.45 32.95 31.74 29.30 26.68 24.74 25.17 26.07 24.15 23.03 21.82 19.80 18.49 17.35 16.94 15.60 14.89 14.25 14.48 13.78 13.09 12.28
Common Stock
100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K
Retained Earnings
724M 589.6M 447.7M 294M 84.5M -5.3M 29.2M 81.1M -48.7M -113.7M -157.1M -304.8M -387.9M -483.4M -406.8M -495.8M -564.3M -547.4M -635.8M -628.5M -651M -693.3M
Comprehensive Income
5.1M 400K 13.1M 13.2M 12.5M 9M 5.8M 14.5M 2.5M 3.3M 7M -1.7M -1.1M -2.7M -7.9M -14M -12.2M -9.3M -1.7M 400K 700K 1M
Shareholders Equity
3.69B 3.41B 3.25B 3B 2.69B 2.54B 2.59B 2.72B 2.51B 2.39B 2.23B 2B 1.85B 1.68B 1.71B 1.54B 1.42B 1.39B 1.37B 1.35B 1.28B 1.21B
Total Investments
296.6M 2.53B 1.95B 1.89B 1.67B 1.66B 1.71B 1.65B 1.68B 1.68B 1.63B 1.39B 1.33B 1.17B 1.13B 1.04B 974M 1.03B 994.9M 1B 893.6M 809.6M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.